Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Bonus Article 3 Stocks Under $5 With Strong Analyst Upside PotentialReported by Chris Markoch. Article Published: 2/24/2026. 
Key Points - Grab Holdings is gaining analyst support as revenue growth and its first full year of profitability highlight long-term opportunity in Southeast Asia’s expanding digital economy.
- Vaxart offers speculative biotech upside with its oral vaccine platform targeting influenza, norovirus, and COVID-19, creating a high-risk, high-reward setup.
- ThredUp is positioned to benefit from the fast-growing resale market, with strong institutional ownership and industry forecasts pointing to sustained secondhand demand.
- Special Report: [Sponsorship-Ad-6-Format3]
At a time when many investors are rotating out of speculative penny stocks, others continue to embrace the risk-reward dynamic. Stocks that trade for under $5 carry a certain amount of risk: many of these companies are unprofitable, and some generate little to no revenue. In almost every case these are small-cap companies, and small caps have been beaten up over the last several years. Even with the Russell 2000 showing some signs of growth, that strength hasn't been broadly reflected across the small-cap sector. Silver: 20% + 68%
Tim Plaehn just found a Silver ETF that delivers monthly income (up to 20% in annual distributions) plus share appreciation (68% in 5 months). The precious metal has become one of the best investments for growth AND income right now. Click here and start to collect in the next 30 days. That could change in 2026, particularly if the economic outlook continues to improve. In that scenario, money may flow back into speculative stocks — but, as with any market segment, quality matters. One way to filter for quality is to look for names with positive analyst sentiment. That's the case with these three stocks. Each lets an investor start a meaningful position with a modest outlay while still offering the potential for significant upside over the next five years. Profitability Milestone Meets Long-Term Emerging Market Growth Emerging-market equities are expected to be among the winners in 2026. That hasn't been the case so far for Grab Holdings Inc. (NASDAQ: GRAB), which is down about 15% year to date. Based in Singapore, Grab operates a super app that combines technology, e-commerce and fintech services. One reason for the stock's recent pullback is its proposed merger with Indonesian ride-hailing competitor GoTo. The deal is not finalized and could be affected by significant legislative changes in Indonesia that might limit the company's earnings potential in that market. The company also missed the top-line estimate slightly in its Q4 2025 earnings report. For context, revenue was up 19% year over year (YOY), and the period represented the first full year of profitability in the company's history. Analysts are forecasting roughly 120% earnings growth over the next 12 months. That helps explain why sentiment remains bullish. GRAB has a consensus price target of $6.47, implying about 54% upside from its current level. High-Risk Biotech With Platform Potential Many penny stock investors gravitate to the biotechnology sector, where risk and reward are often closely linked. One company worth watching is Vaxart Inc. (OTCMKTS: VXRT). It is the only name on this list that fits the traditional penny stock definition — at the time of writing it was trading just over $0.60 a share. VXRT doesn't have heavy analyst coverage, but the single analyst to rate the stock in the past 12 months gave it a Buy with a $2 price target. It's not uncommon for analysts to overlook some biotech firms. Vaxart is a clinical-stage company, meaning all of its candidates are still in clinical trials. The upside is straightforward: the company is developing oral vaccines primarily for influenza, norovirus and COVID-19. Beyond convenience and alleviating fear of needles, Vaxart says its oral-platform approach may generate a broader immune response and offer wider protection (company presentation). Institutional ownership of VXRT is only about 18%, but inflows outweigh outflows by nearly 10-to-1 in dollar volume (source). Resale Tailwinds Could Turn Today's Losses Into Tomorrow's Gains ThredUp Inc. (NASDAQ: TDUP) is down about 33% in 2026, but a broader look is instructive: TDUP is up more than 66% over the last 12 months, suggesting this may be a routine pullback as investors avoid companies that aren't yet profitable. In ThredUp's case, that caveat is important — the company operates an online consignment and thrift marketplace that's gaining traction with Gen Z consumers, as reflected in revenue growth. In the most recent quarter, revenue rose 12.5% YOY. ThredUp cites a GlobalData 2025 market survey forecasting that the U.S. secondhand market's gross merchandise value will grow at a compound annual growth rate (CAGR) of 9% through 2029. Institutions own an impressive 89% of TDUP stock. Buying has outpaced selling two-to-one by dollar volume and three-to-one by the number of buyers versus sellers. That said, short interest sits near 17%, which can add short-term volatility. The consensus price target from six analysts is $12.50, implying upside of more than 190% from the current price.
| 
